NCT07123896Not yet recruitingNot Applicable
Arrhythmia Cohort Study
Beijing Anzhen Hospital1 site in 1 country10,000 target enrollmentStarted: August 24, 2025Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 10,000
- Locations
- 1
- Primary Endpoint
- Arrhythmia recurrence
Study Overview
Brief Summary
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients hospitalized for any type of arrhythmia
Exclusion Criteria
- •Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.
Arms & Interventions
Treatment
Intervention: Normal treatment with catheter ablation or medicine (Device)
Treatment
Intervention: Drug Treatment (Drug)
Outcomes
Primary Outcomes
Arrhythmia recurrence
Time Frame: 1 year
Recurrence of the arrhythmia after treatment
All-cause death
Time Frame: 1 year
Death due to any reason
Secondary Outcomes
- Arrhythmia recurrence(5 year)
- All-cause death(5 year)
- Cardiovascular death(5 year)
- Heart failure(5 year)
- Cardiovascular hospitalization(5 year)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
A Study of Patients With HER2-Positive Metastatic Breast CancerBreast CancerNCT00105456Genentech, Inc.1,000
Recruiting
Not Applicable
Characterization of Arrhythmia-induced CardiomyopathyArrhythmia-induced Cardiomyopathy (AiCM)CardiomyopathyNCT05662293University Hospital, Basel, Switzerland2,700
Active, not recruiting
Early Phase 1
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial FibrillationAFibNCT03929718Piedmont Healthcare50
Completed
Not Applicable
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) RegistrySystemic Lupus ErythematosusNCT01729455GlaxoSmithKline3,138
Completed
Not Applicable
A Study of Prolonged Electrocardiographic Monitoring in Patients With Heart Failure in Sinus Rhythm or Atrial FibrillationHeart FailureAtrial FibrillationNCT02707744Imperial College London100